Mild Traumatic Brain Injury Registry
mTBI
1 other identifier
observational
40
1 country
1
Brief Summary
The purpose of the study is to gather information about patients with mild traumatic brain injury in order to develop guidelines for evaluation and treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2012
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2012
CompletedFirst Submitted
Initial submission to the registry
September 17, 2012
CompletedFirst Posted
Study publicly available on registry
September 20, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2015
CompletedApril 25, 2022
February 1, 2015
2.8 years
September 17, 2012
April 19, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To determine which biomarkers and/or clinical variables correlate with long term symptoms of mild traumatic brain injury.
6 months
Study Arms (1)
Mild TBI
Patients who have been diagnosed with a mild brain injury.
Eligibility Criteria
Patients who are seen in the CMC emergency department who have a clearly defined history of traumatic brain injury that produced at least transient alteration in consciousness, or change in mood, together with one or more persistent symptom lasting longer than one hour after impact. Symptoms can include head pain, nausea, dizziness, disequilibrium, confusion, amnesia, or irritability. All patients must be awake and alert (GCS 13 to 15), and must be enrolled within 72 hours of the injury.
You may qualify if:
- Must have defined history of CHI (closed head injury) which produced an altered state of consciousness or mood
- Must be awake and alert (Glasgow Coma Scale 13-15)
- Must be enrolled within 72 hours of injury
- Must have CT or MRI neuroimaging performed
You may not qualify if:
- Diabetes Mellitus with severe complications
- Intoxication at time of enrollment
- Major psychiatric disorder that is poorly controlled
- Prior stroke
- History of Social Security defined "disability
- Uncontrolled Seizure Disorder
- Incarceration or arrest
- Concurrent Injury requiring hospitalization
- Use of anticoagulant drugs
- Any condition the investigator deems as inappropriate for patient enrollment
- Personality disorder
- Heart, liver or kidney failure defined using common clinical practice guidelines
- Baseline cognitive impairment
- Homelessness
- TBI associated with interpersonal violence
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Carolinas Medical Center
Charlotte, North Carolina, 28203, United States
Biospecimen
Blood samples will be obtained in the emergency room and processed for future analysis. Depending on the blood volume obtained, up to two citrate, two EDTA, and one Paxgene tube will be collected.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lori M Grafton, MD
Wake Forest University Health Sciences
- PRINCIPAL INVESTIGATOR
Michael A Gibbs, MD
Wake Forest University Health Sciences
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 17, 2012
First Posted
September 20, 2012
Study Start
April 1, 2012
Primary Completion
January 1, 2015
Study Completion
January 1, 2015
Last Updated
April 25, 2022
Record last verified: 2015-02